Thalidomide film to air in Germany

May 19, 2007

A film about the drug thalidomide, which caused thousands of children to be born disabled, will air on German television.

Grunenthal pharmaceuticals had tried to get the movie banned, saying it was an unfair depiction of the scandal but judges in Hamburg ruled the movie is clearly fiction, Deutsche Welle said Friday.

The film, called "Contergan: Just One Tablet," is scheduled to air on public television in August.

Contergan was the German name for the drug given to pregnant women to treat morning sickness in the 1950s and the early 1960s. It was later discovered that the drug caused severe damage to the limbs and internal organs of unborn children.

Dr. Annette Fusenig from Grunenthal had criticized the film for failing to properly distinguish between fact and fiction.

The drug maker said issues such as compensation and general treatment of the victims are not fairly depicted in the film, the newspaper said.

Copyright 2007 by United Press International

Explore further: Safety review of bone growth product ushers in new era of data sharing

add to favorites email to friend print save as pdf

Related Stories

Implantable silk optics multi-task in the body

Nov 28, 2012

Tufts University School of Engineering researchers have demonstrated silk-based implantable optics that offer significant improvement in tissue imaging while simultaneously enabling photo thermal therapy, ...

Neutrons answer shampoo formulation puzzle

Dec 12, 2011

(PhysOrg.com) -- Scientists at the Institut Laue-Langevin have used neutrons to solve a long-standing mystery about the surface properties of polyelectrolyte/surfactant mixtures, such as those used in many ...

Japan 3-D pop avatar a real-world hit

Jun 12, 2011

Japanese teenage pop sensation Miku Hatsune has millions of smitten fans, a string of top hits and an image entirely unblemished by drug use, scandals or celebrity meltdowns.

Recommended for you

Hormonal therapy for transsexualism safe and effective

3 hours ago

Hormonal therapy for transsexual patients is safe and effective, a multicenter European study indicates. The results will be presented Saturday at The Endocrine Society's 95th Annual Meeting in San Francisco.

Royalty Pharma lets Elan takeover bid expire

6 hours ago

Royalty Pharma has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer.

FDA approves new silicone breast implants

Jun 17, 2013

(HealthDay)—MemoryShape breast implants have been approved by the U.S. Food and Drug Administration for breast augmentation in women 22 and older, and for breast reconstruction, the FDA said Friday.

User comments : 0

More news stories

Study evaluates procedures for diagnosing sarcoidosis

Among patients with suspected stage I/II pulmonary sarcoidosis who were undergoing confirmation of the condition via tissue sampling, the use of the procedure known as endosonographic nodal aspiration compared with bronchoscopic ...

Respect may be the key to stopping patient 'no shows'

People with HIV are more likely to keep their scheduled medical appointments—and their disease under control—if they feel their physician listens, explains things clearly and knows them as a person, not just a "case," ...